# Crosslink Therapeutics Inc. — Form D

Crosslink Therapeutics Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-05-15. The offering totals $8.0M, of which $4.3M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2025-05-15
- Form: D
- Accession: 0002067583-25-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $4.3M
- Remaining: $3.8M
- Investors: 6
- Date of first sale: 2025-04-17
- Revenue range: Decline to Disclose
- SEC file number: 021-546247

## Issuer

- Name: Crosslink Therapeutics Inc.
- CIK: 0002067583
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 349-351 NEWBURY STREET, BOSTON, MA, 02115
- Phone: 404-861-1253

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Rodolfo D Chaparro | Director | Boston, MA |
| Cameron D Gallagher | Director | Boston, MA |
| Ronald D Seidel, III | Director | Boston, MA |
| Lou D Tartaglia | Director | Boston, MA |
| Andrew D King | Executive Officer | Boston, MA |
| Ronald D Seidel, III | Executive Officer | Boston, MA |

## More

- [CIK 2067583 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2067583&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002067583-25-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.